Table 2 Association between biological age acceleration and the risk of COVID-19.
From: Genetic and phenotypic analysis of the causal relationship between aging and COVID-19
Biological age measurement | Outcome | OR | 95% CI | P |
|---|---|---|---|---|
Phenotypic age | COVID19 incidence (All) | 1.28 | 1.25−1.31 | 8.4e−82 |
Phenotypic age | Case fatality (All) | 1.19 | 1.04−1.35 | 1.1e−02 |
Phenotypic age | COVID19 incidence (Not frail) | 1.12 | 1.04−1.2 | 1.9e−03 |
Phenotypic age | Case fatality (Not frail) | 1.72 | 1.17−2.51 | 5.4e−03 |
Phenotypic age | COVID19 incidence (Frail) | 1.26 | 1.23−1.3 | 3.7e−62 |
DOSI | COVID19 incidence (All) | 1.31 | 1.26−1.38 | 9.5e−32 |
DOSI | COVID19 incidence (Not frail) | 1.09 | 1.01−1.19 | 3.6e−02 |
DOSI | Case fatality (Not frail) | 2.44 | 1.45−4.06 | 7.7e−04 |
DOSI | COVID19 incidence (Frail) | 1.35 | 1.28−1.42 | 3.6e−28 |
Physical activity | COVID19 incidence (All) | 0.95 | 0.93−0.96 | 9.1e−19 |
